ASP Isotopes Inc. entered into Series Seed-1 Preferred Stock Purchase Agreement with Opeongo, Inc. valued at $2.2952 per share (effective 2026-01-26).
“On January 26, 2026, ASP Isotopes Inc., a Delaware corporation (“ ASP Isotopes ” or the “ Company ”), entered into a Series Seed-1 Preferred Stock Purchase Agreement (the “ Purchase Agreement ”) with Opeongo, Inc., a Delaware corporation (“ Opeongo ”), pursuant to which the Company agreed to purchase from Opeongo 4,356,918 shares of Opeongo’s Series Seed-1 Preferred Stock, $0.0001 par value per share (the “ Series Seed-1 Preferred Stock ”), at a price of $2.2952 per share”
M&A Transactions
ASP Isotopes Inc. completed an acquisition involving Renergen Limited (closed 2026-01-06).
“On the Closing Date, ASP Isotopes acquired all of the issued Renergen Ordinary Shares from Renergen shareholders in exchange for shares of Company Common Stock at an exchange ratio of 0.09196 shares of Company Common Stock for each Renergen Ordinary Share (the “Consideration Shares”) through the implementation of the Scheme, resulting in the issuance of an aggregate of 14,270,000 Consideration Shares.”
Debt Financings
ASP Isotopes Inc. incurred convertible notes of $64.3 million with certain institutional and individual investors at 8.0% per annum maturing five-year anniversary of the initial closing.
“investors who are not a person in the United States or a U.S. Person (within the meaning of Rule 902(k) of Regulation S promulgated under the Securities Act) for approximately $64.3 million of QLE 2025 Notes. The initial closing of the offering is expected to be on or about November 17 or 18, 2025, subject to satisfaction of customary closing conditions, and at such”
Sipho Maseko was appointed as Director at ASP Isotopes Inc..
“the Board appointed Sipho Maseko as director”
Hendrik Strydom departed as Director at ASP Isotopes Inc..
“Dr. Hendrik Strydom, PhD, Chief Technology Officer of the Company, stepped down as a member of the board of directors of the Company”
Robert Ainscow departed as Chief Operating Officer at ASP Isotopes Inc..
“Mr. Ainscow will resign as the Company’s Chief Financial Officer as of the Start Date and will continue in his role as Chief Operating Officer.”
Heather Kiessling was appointed as Chief Financial Officer at ASP Isotopes Inc..
“On June 10, 2024, the Board of Directors (the “Board”) of ASP Isotopes Inc. (the “Company”) appointed Heather Kiessling as the Chief Financial Officer of the Company, effective as of July 1, 2024”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.